Robeco Institutional Asset Management B.V. cut its position in Stericycle Inc. (NASDAQ:SRCL) by 0.9% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 348,193 shares of the company’s stock after selling 3,238 shares during the period. Robeco Institutional Asset Management B.V. owned approximately 0.41% of Stericycle worth $27,904,000 as of its most recent SEC filing.

Other hedge funds also recently bought and sold shares of the company. Balentine LLC raised its position in shares of Stericycle by 15.0% in the second quarter. Balentine LLC now owns 1,224 shares of the company’s stock valued at $127,000 after buying an additional 160 shares during the last quarter. NEXT Financial Group Inc raised its position in Stericycle by 78.0% in the third quarter. NEXT Financial Group Inc now owns 1,620 shares of the company’s stock worth $130,000 after buying an additional 710 shares in the last quarter. Pinkerton Retirement Specialists LLC purchased a new position in Stericycle during the second quarter worth approximately $131,000. Parkside Financial Bank & Trust raised its position in Stericycle by 2.9% in the second quarter. Parkside Financial Bank & Trust now owns 1,432 shares of the company’s stock worth $149,000 after buying an additional 41 shares in the last quarter. Finally, Amica Retiree Medical Trust purchased a new position in Stericycle during the third quarter worth approximately $150,000. 92.46% of the stock is owned by institutional investors and hedge funds.

Institutional Ownership by Quarter for Stericycle (NASDAQ:SRCL)

Shares of Stericycle Inc. (NASDAQ:SRCL) traded down 0.62% during midday trading on Tuesday, hitting $75.60. 98,054 shares of the stock traded hands. The company has a market capitalization of $6.43 billion, a P/E ratio of 27.48 and a beta of 0.17. The stock has a 50 day moving average of $75.43 and a 200 day moving average of $88.39. Stericycle Inc. has a 1-year low of $72.20 and a 1-year high of $128.94.

Stericycle (NASDAQ:SRCL) last announced its quarterly earnings data on Thursday, October 27th. The company reported $1.24 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.17 by $0.07. Stericycle had a return on equity of 15.33% and a net margin of 7.52%. The company had revenue of $890.10 million for the quarter, compared to analysts’ expectations of $899.87 million. During the same quarter in the prior year, the business posted $1.08 EPS. The business’s revenue was up 23.9% compared to the same quarter last year. Equities research analysts predict that Stericycle Inc. will post $4.74 earnings per share for the current fiscal year.

WARNING: This piece was published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece on another website, it was stolen and reposted in violation of U.S. and international copyright and trademark laws. The legal version of this piece can be read at https://www.thecerbatgem.com/2016/11/29/stericycle-inc-srcl-shares-sold-by-robeco-institutional-asset-management-b-v.html.

A number of research firms have recently commented on SRCL. Jefferies Group reissued a “buy” rating and issued a $125.00 price target on shares of Stericycle in a research report on Tuesday, August 23rd. Macquarie began coverage on shares of Stericycle in a research report on Thursday, August 25th. They issued a “neutral” rating and a $96.00 price target on the stock. Imperial Capital dropped their price target on shares of Stericycle from $93.50 to $80.00 and set an “underperform” rating on the stock in a research report on Friday, September 9th. RBC Capital Markets reissued an “underperform” rating and issued a $77.00 price target (down previously from $89.00) on shares of Stericycle in a research report on Monday, September 19th. Finally, Royal Bank Of Canada dropped their price target on shares of Stericycle from $89.00 to $77.00 and set an “underperform” rating on the stock in a research report on Monday, September 19th. Four investment analysts have rated the stock with a sell rating, nine have issued a hold rating and four have issued a buy rating to the company. The company has an average rating of “Hold” and a consensus price target of $92.75.

In related news, EVP John P. Schetz sold 1,398 shares of the stock in a transaction on Wednesday, September 14th. The stock was sold at an average price of $81.85, for a total value of $114,426.30. Following the sale, the executive vice president now owns 1,088 shares in the company, valued at approximately $89,052.80. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 3.30% of the stock is owned by corporate insiders.

About Stericycle

Stericycle, Inc is a business-to-business services provider with a focus on regulated and compliance solutions for healthcare, retail and commercial businesses. The Company’s solutions include the collection and processing of specialized waste for disposal, the collection of personal and confidential information for secure destruction, and a range of training, consulting, recall/return, communication and compliance services.

5 Day Chart for NASDAQ:SRCL

Receive News & Stock Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related stocks with our FREE daily email newsletter.